Judge Finds Drug Makers Liable For Inflating Costs

Law360, New York (June 21, 2007, 12:00 AM EDT) -- A federal judge has issued a stinging rebuke to three pharmaceutical companies in a massive antitrust class action, finding that they acted unfairly and deceptively by causing the publication of artificially inflated average wholesale prices for various prescription drugs.

After a twenty-day bench trial, U.S. District Judge Patti B. Saris said in findings of fact and conclusions of law filed Thursday that AstraZeneca, Bristol-Myers Squibb Co. and Schering-Plough Corp., a subsidiary of Warrick, inflated the AWP for the drugs, which grossly exceeded actual physician acquisition costs....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.